Bacticent™ KB - Antimicrobial Coatings for Medical Devices |
|
Introducing Bacticent KB brand broad-spectrum antimicrobial coatings are a powerful new weapon in the fight against health care associated infections. Health care associted infections affect several million patients world-wide each year. The impact to the patient as a result of infection is quite significant, ranging from discomfort to death, loss of time and money due to prolonged hospital stays and serious subsequent consequences that may result in future hospitalization and a shorter lifespan. The Centers for Disease Control and Prevention (CDC) estimates that there are approximately 99,000 deaths per year in the US attributed to health care associated infections. The health care system also suffers as a result of health care associated infections, exposing health care workers to additional risk, consuming valuable resources, and incurring additional expenses, which are increasingly not reimbursed. In the US the cost of treating a health care associated infection is estimated between $20,000 and $25,000 per patient. Current best health care practices suggest the use of medical devices with an antimicrobial coating go a long way toward eliminating these deadly infections. Bacticent KB features the highly effective and patent-pending synergistic combination of chlorhexidine and protamine sulfate precisely dosed and delivered right from the surface of your medical device. Engineered to prevent the adhesion of biofilm and to outperform the commercially available silver and nitrofurazone coated devices against the most common bacteria associated with medical device-based infections. Bacteria Bacticent KB is effective against the most common gram negative and gram positive bacteria associated with nosocomial infections.
Biofilms An estimated 80% of all human bacterial infections involve biofilms. Biofilms are created when bacteria adheres to the surface of a medical device. Biofilms form a protective fortress in which colonies of bacteria are shielded from conventional antibiotic treatment and the body’s immune system. Safely inside the biofilm’s protective polymeric matrix, the bacteria rapidly multiply and disperse, greatly increasing the risk to the patient, prolonging the hospital stay, and driving up the overall cost of treatment. The Power of Two
The two active ingredients in Bacticent KB act in synergy to repel biofilm formation and break through the bacteria’s cell membrane defenses delivering a direct hit to the cytoplasm. In both in vitro and in vivo testing, this On Your Medical Device Bacticent KB can be easily applied to a variety of common medical device substrates including Silicone, Polyurethane, Polyvinyl Chloride (PVC), Latex, Stainless Steel, Titanium and Nitinol without affecting their performance. Harland Medical Systems will work with you to tune Bacticent KB’s dosing and elution profile to meet the requirements of your specific medical device. |
